16.8% Revenue Growth and 28.8% Service Volumes Increase GUANGZHOU, China, July 10, 2026 (GLOBE NEWSWIRE) — YSX TECH. CO., LTD (NASDAQ: “YSXT”) (the “Company”), a Cayman Islands exempted company that, through its variable interest entities in China, provides comprehensive business solutions mainly for insurance companies and brokerages in China, today announced its financial results for the fiscal year ended March 31, 2026. Management Commentary “Fiscal 2026 was a year of operational scaling and strategic realignment for YSX,” said Mr. Jie Xiao, CEO of YSX TECH. CO., LTD. “We drove our top-line revenue to $83.5 million, representing a 16.8% year-over-year increase, fueled primarily by a 28.8% increase in our service volumes. By intentionally pivoting our business development efforts toward insurance brokerages...

DEERFIELD, Ill., July 10, 2026 (GLOBE NEWSWIRE) — BAB, Inc. (OTCQB: BABB), announced its financial results for the second quarter ended May 31, 2026. For the quarter ended May 31, 2026, BAB had revenues of $804,000 and net income of $187,000, or $0.03 per share earnings, versus revenues of $808,000 and net income of $154,000, or a $0.02 per share, for the same quarter last year. Our total revenue for the three months ended May 31, 2026 decreased compared to the prior period due to a decrease in marketing fund expenses, which drive the recognition of marketing fund revenue. Under U.S. GAAP, we recognize marketing fund revenue at the time the related marketing fund expenses are incurred. As marketing fund revenue and expense directly offset each other in any given period, the decline has no impact on net income.   For the six months...

Segments (EURm) Q2/26 Q2/25 Change 6m/26 6m/25 ChangeSupermarkets 147,0 155,7 -5,6% 289,4 304,0 -4,8%Department stores 24,9 25,7 -3,0% 47,8 48,4 -1,4%Cars 76,2 45,1 68,8% 132,0 82,5 60,1%Security 5,2 4,4 20,2% 10,8 9,0 20,0%Real Estate 1,9 1,9 -3,4% 3,7 3,9 -4,8%Total sales 255,2 232,8 9,6% 483,6 447,8 8,0%             Supermarkets 1,9 3,4 -43,6% 1,9 4,0 -53,9%Department stores -0,1 0,0 NA -1,8 -1,7 7,4%Cars 2,7 1,6 64,4% 4,8 2,3 105,2%Security -0,3 -0,3 -2,2% -0,3 -0,4 -38,1%Real Estate 2,4 2,4 -0,8% 4,5 4,6 -1,3%IFRS 16 -0,5 -0,5 -1,2% -0,9 -1,0 -1,7%Total profit before tax 6,2 6,6 -7,2% 8,2 7,9 3,4%The Group’s unaudited consolidated sales revenue for the second quarter of 2026 amounted to 255.2 million euros, representing a year-on-year increase of 9.6%. The sales revenue for the first...

GAAP Measures:Segment profits were $59.9 million during the 13 week period ended May 31, 2026 (the “second quarter”), a decrease of $9.4 million compared to the same period in 2025. Impairment charge on right-of-use assets of $7.5 million during the 13 week period as a result of management’s decision to close 68 of its corporate locations in the coming months. Net income attributable to owners decreased to $15.4 million, or $0.67 per diluted share compared to $57.3 million, or $2.49 per diluted share in Q2-25. Cash flows provided by operating activities increased 25% or $8.7 million to $43.0 million compared the same period in 2025. Long-term debt repayments of $15.7 million during the 13 week period with net repayments of $77.5 million since Q2-25.Management Key Performance Indicators:6 net store openings during the 13 week...

(2026-07-10) Kitron today reported record quarterly revenue and operating profit, driven primarily by accelerating demand in the Defence/Aerospace market sector but also growth in other market sectors. Kitron’s revenue for the second quarter was EUR 295.7 million, an increase of 72 per cent from 172.2 million in the same quarter last year. The Defence/Aerospace market sector continued to lead, but all market sectors grew compared to a year ago. Second-quarter operating profit (EBIT) was EUR 28.3 million, compared with 15.0 million in the same quarter last year. Profitability expressed as EBIT margin was 9.6 per cent, compared with 8.7 per cent in the same quarter last year. This is in line with the strategic target of maintaining an EBIT margin above 9 per cent. The order backlog ended at EUR 794.3 million, an increase of 56 per...

MONTREAL, July 09, 2026 (GLOBE NEWSWIRE) — Velan Inc. (TSX: VLN) (“Velan” or the “Company”), a world-leading manufacturer of industrial valves, announced today financial results for its first quarter ended May 31, 2026. All amounts are expressed in U.S. dollars unless indicated otherwise. FIRST-QUARTER HIGHLIGHTS FROM CONTINUING OPERATIONS IFRS MEASURESSales of $57.8 million, compared to $72.2 million last year, reflecting the geopolitical and regional conflicts which resulted in shipments being deferred to subsequent periods, with the majority expected to be delivered by the end of the fiscal year. Gross profit of $11.4 million or 19.6% of sales, versus $20.6 million or 28.6% of sales last year, due to lower business volume and higher provisions. Net loss1 of $9.4 million ($0.44 per share) versus net income of $17.8 million...

TORONTO, July 09, 2026 (GLOBE NEWSWIRE) — Golconda Gold Ltd. (“Golconda Gold” or the “Company”) (TSX-V: GG; OTCQX: GGGOF) is pleased to announce quarterly production of 3,648 ounces of gold for the second quarter of 2026 (“Q2”) at its Galaxy Gold Mine (“Galaxy”), consistent with gold production compared to Q1 2026 and a 20% increase on Q2 2025. The Q2 production numbers are as follow:Mining     Q22026 Q1 2026 YTD2026 FY2025 Q22025PrincetonOre Mined (t) 14,110 17,953 32,063 59,428 12,346Ore Grade (g/t) 3.75 3.41 3.56 3.88 4.63Waste (t) 244 274 518 952 243GalaxyOre Mined (t) 26,049 26,089 52,138 76,000 19,135Ore Grade (g/t) 2.56 2.77 2.66 3.13 3.05Waste (t) 143 128 271 371 113TotalOre Mined (t) 40,159 44,042 84,201 135,428 31,481Ore Grade (g/t) 2.98 3.03 3.01 3.46 3.67Waste (t) 387 402 789 1,323 356Processing     Q22026 Q1...

TULSA, Okla., July 09, 2026 (GLOBE NEWSWIRE) — ONEOK, Inc. (NYSE: OKE) will release second-quarter 2026 earnings after the market closes on Aug. 3, 2026. Members of ONEOK’s management team will participate in a conference call the following day. What:               ONEOK second-quarter 2026 earnings conference call and webcast When:              Aug. 4, 2026, at 11 a.m. Eastern (10 a.m. Central) Where:            1) Conference call: Dial 800-330-6710 and use confirmation code: 3334626                         2) Webcast: Join at www.oneok.com If you are unable to participate in the conference call or the webcast, a recording will be available at www.oneok.com for one year. —————————————————————————————————————————————————————————————————————————————————————————————————————— At...

Results Consistent with Preliminary Ranges  $16.9 million of Net Income and $76.5 million of Adjusted EBITDA Reported for Fiscal 2026 BNC First Day Program Revenue Increases 28% to $760.1 million Total Net Debt Decreases 33% Year-Over-Year to $62.6 million Company Reiterates Fiscal 2027 Outlook of $85 million to $92 million of Adjusted EBITDA FLORHAM PARK, N.J., July 09, 2026 (GLOBE NEWSWIRE) — Barnes & Noble Education, Inc. (NYSE: BNED), (“Barnes & Noble Education,” “BNED,” “the Company,” “we,” “us,” “our”), a leading solutions provider for the education industry, today announced its financial results for the fiscal year ended May 2, 2026. FY2026 Financial Results Full-year revenue in fiscal 2026 was $1.715 billion, an increase of $104.6 million, or 6.5%, over the prior year. Fiscal 2026 comprised 52 weeks compared with...

Entered into global collaboration with Roche for bexobrutideg, with potential total payments of up to $2.3 billion, including $700 million upfront payment Co-development, co-commercialization collaboration includes comprehensive clinical development plan in malignant hematology and enables expansion of bexobrutideg into chronic spontaneous urticaria (CSU) and multiple sclerosis (MS) Presented clinical data update at the European Hematology Association (EHA) supporting bexobrutideg’s potential as a best-in-class BTK degrader across multiple lines of therapy in CLL Well capitalized with cash, cash equivalents and marketable securities of $443.5 million as of May 31, 2026, and pro-forma cash of approximately $1.14 billion, including the expected $700 million upfront payment upon closing of the Roche collaboration BRISBANE, Calif., July...